🇺🇸 FDA
Patent

US 9567564

Progenitor cells from Wharton's jelly of human umbilical cord

granted A61KA61K35/51

Quick answer

US patent 9567564 (Progenitor cells from Wharton's jelly of human umbilical cord) held by Tissue Regeneration Therapeutics Inc. expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tissue Regeneration Therapeutics Inc.
Grant date
Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K35/51